| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $728.7M | +23.3% |
| Cost of Revenue | $274.5M | +27.4% |
| R&D Expense | $73.9M | +6.4% |
| SG&A Expense | $205.4M | -3.8% |
| Operating Income | -$167.7M | +35.3% |
| Interest Expense | $10.9M | +49.8% |
| Pre-tax Income | -$186.4M | +33.6% |
| Income Tax | $1.0M | +169.6% |
| Net Income | -$187.5M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $131.7M | +8.8% |
| Accounts Receivable | $170.1M | +60.0% |
| Current Assets | $309.8M | +31.0% |
| Total Assets | $550.7M | +18.1% |
| Current Liabilities | $176.4M | +37.0% |
| Long-term Debt | $184.1M | +0.1% |
| Total Liabilities | $370.2M | +9.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $90.5M | +15.3% |
| Capital Expenditures | $20.5M | -7.9% |
| Investing Cash Flow | -$54.2M | -11.9% |
| Financing Cash Flow | -$25.7M | -103.2% |
| Free Cash Flow | $70.0M | +24.5% |
| +32.9% |
| EPS (Basic) | -$1.20 | +40.3% |
| EPS (Diluted) | -$1.20 | +40.3% |
| Stockholders' Equity |
| $180.5M |
| +41.0% |